NCT02023242View on ClinicalTrials.gov

Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes

NACompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

August 31, 2017

Study Completion Date

January 31, 2018

Conditions
Primary Open Angle GlaucomaPseudoexfoliative GlaucomaPigmentary Glaucoma
Interventions
DEVICE

Hydrus Microstent

Device inserted into Schlemm's canal to enhance aqueous flow from the anterior chamber.

DEVICE

iStent Trabecular Micro Bypass

Device inserted into Schlemm's canal to enhance aqueous flow from the anterior chamber.

Trial Locations (1)

92618

Contact Richard Hope at Ivantis, Irvine

Sponsors

Lead Sponsor

Ivantis, Inc.
All Listed Sponsors
lead

Ivantis, Inc.

INDUSTRY